Invesco Nasdaq Biotechnology ETF

Invesco Nasdaq Biotechnology ETF (IBBQ)

Description

The investment seeks to track the performance of the NASDAQ Biotechnology Index. The IBBQ ETF contains 268 constituents. It is focused on holdings in the North America region.

Price $18.95 as of 2022-10-20

Cost/Risk/Yield

Dividend yield	1.18%
Expense ratio
Average spread	0.211%
1Y roundtrip cost	0.211%

Historic prices

Total Returns (including dividends)

Returns by Year

Returns by Period

Monthly returns heatmap

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2022	-12.1%	-3.9%	4.6%	-9.7%	-1.2%	1.1%	3.9%	-0.7%	-2.3%	0.2%			-20.2%
2021							-0.3%	4.4%	-4.9%	-1.9%	-3.8%	-1.4%	-7.9%
	-12.1%	-3.9%	4.6%	-9.7%	-1.2%	1.1%	3.6%	3.7%	-7.2%	-1.8%	-3.8%	-1.4%

Historical Dividends

Dividends by Year

Dividend Yields by Year

Monthly dividend heatmap

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2022			0.04			0.04			0.04				0.12
2021									0.04			0.10	0.15
	0.00	0.00	0.04	0.00	0.00	0.04	0.00	0.00	0.08	0.00	0.00	0.10

Sectors and Top Holdings

Security	% Assets
Amgen Inc.	7.91%
Moderna, Inc.	7.90%
Gilead Sciences, Inc.	7.08%
Regeneron Pharmaceuticals, Inc.	5.85%
Illumina, Inc.	5.65%
Vertex Pharmaceuticals Incorporated	3.98%
Biogen Inc.	3.39%
Seagen, Inc.	2.80%
Horizon Therapeutics Public Limited Company	2.37%
BioNTech SE Sponsored ADR	2.00%
Astrazeneca PLC Sponsored ADR	1.70%
Alnylam Pharmaceuticals, Inc	1.66%
BeiGene, Ltd. Sponsored ADR	1.59%
Royalty Pharma Plc Class A	1.47%
Incyte Corporation	1.29%
Top 15 Weights	56.64%

Compare with similar ETFs

	IBBQ	GERM	IBB	IDNA	IEIH	WDNA
Product name	Invesco Nasdaq Biotechnology ETF	ETFMG Treatments Testing and Advancements ETF	iShares Nasdaq Biotechnology ETF	iShares Genomics Immunology and Healthcare ETF	iShares Evolved U.S. Innovative Healthcare ETF	WisdomTree BioRevolution Fund
Issuer	Invesco	ETF Managers Group	iShares	iShares	iShares	WisdomTree
Price	$18.95	$20.64	$117.58	$26.91	$34.1348	$16.773
Expense Ratio	0%	0.68%	0.45%	0.47%	0.18%	0.45%
Average Spread	0.211%	0.775%	0.017%	0.223%	0.146%	0.894%
AUM	$33,791,400	$30,340,400	$7,490,990,000	$184,587,000	$40,743,700	$0
Shares	1,783,189	1,469,979	63,709,707	6,859,406	1,193,612	0
Average Daily Volume	8,192	2,471	1,968,141	54,549	2,776	410
Home page	Visit external site	Visit external site	Visit external site	Visit external site	Visit external site	Visit external site
Inception Date	2021-06-11	2020-06-17	2001-02-05	2019-06-11	2018-03-21	2021-06-03
Index Tracked	NASDAQ Biotechnology Index	Prime Treatments, Testing and Advancements Index	ICE Biotechnology Index	NYSE FactSet Global Genomics and Immuno Biopharma Index	No Underlying Index	N/A
Category	n/a	All Cap Equities	Health & Biotech Equities	Health & Biotech Equities	Health & Biotech Equities	Health & Biotech Equities
Asset Class	Equity	Equity	Equity	Equity	Equity	Equity
Asset Class Size	Large/Mid Caps	Large/Mid/Small Caps	Large/Mid Caps	Large/Mid/Small Caps	Large/Mid Caps	Large/Mid/Small Caps
Value or Growth		Blend	Growth	Blend	Growth
Region	North America	North America	North America	North America	North America	North America
Countries	U.S.	U.S.	U.S.	U.S.	U.S.	Broad
Annual Dividend Rate	$0.224	$0.111	$0.349	$0.392	$0	$0.025
Annual Dividend Yield	0.012%	0.005%	0.003%	0.015%	0.000%	0.001%
Number of Holdings	268	80	267	48	247	114
YTD Return	-19.61%	-41.78%	-22.76%	-38.29%	-3.74%	-29.05%
Beta	0.95	0.94	1.25	0.93	0.88	0.98
Upside Beta	-1.23	-0.20	0.31	0.15	0.55	-1.10
Downside Beta	-1.22	-1.37	0.31	-0.26	0.59	-1.20
Volatility 1Y	28.75%	37.84%	28.90%	37.65%	18.00%	28.82%
Sharpe Ratio 3Y	0.00	0.00	0.20	0.12	0.95	0.00
Treynor Ratio 3Y	0.00	0.00	0.00	0.00	0.01	0.00

Securities Database